Sanofi

IPOL

Manufacturer:

Sanofi

Ipol HCPCS:

90713

HCPCS Code Descriptor:

Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use

Category:

CPT Drug Code

Ipol NDCs:

49281-0860-10, 49281-0860-78

Primary Type:

Vaccine-Polio

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Injection

Ipol CPT Codes:

Potential CPT administration codes for Ipol can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

49281-0860-78, 49281-0860-10

About Ipol:

IPOL is a Vaccine-Polio drug manufactured by Sanofi and administered via the Injection route of administration. The CPT Drug Code: 90713 is aligned to the drug IPOL.

IPOL is used to help prevent the polio virus. This vaccine works by helping the patient’s own antibodies recognize the virus. IPOL is manufactured by Sanofi Pasteur and is aligned to the HCPCS code 90713.

ACCESS PRICING AND MORE BY REGISTERING

90713 Added Date:

NA

90713 Effective Date:

NA

90713 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ipol billing and coding information.
Our team did not identify a source for Ipol patient assistance information. Please reach out to our team if you feel that this is a mistake.
IPOL prescribing information can be found at the link below:
Information regarding IPOL’s side effects can be found at MedlinePlus